2023-03-04から1日間の記事一覧
Lung Cancer 177 (2023) 44–50 A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-gener…